Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2015 Nov 24;1011:e0143363. doi: 10.1371/journal.pone.0143363.
Show Gene links
Show Anatomy links
Positive Allosteric Modulation of Kv Channels by Sevoflurane: Insights into the Structural Basis of Inhaled Anesthetic Action.
Liang Q
,
Anderson WD
,
Jones ST
,
Souza CS
,
Hosoume JM
,
Treptow W
,
Covarrubias M
.
???displayArticle.abstract???
Inhalational general anesthesia results from the poorly understood interactions of haloethers with multiple protein targets, which prominently includes ion channels in the nervous system. Previously, we reported that the commonly used inhaled anesthetic sevoflurane potentiates the activity of voltage-gated K+ (Kv) channels, specifically, several mammalian Kv1 channels and the Drosophila K-Shaw2 channel. Also, previous work suggested that the S4-S5 linker of K-Shaw2 plays a role in the inhibition of this Kv channel by n-alcohols and inhaled anesthetics. Here, we hypothesized that the S4-S5 linker is also a determinant of the potentiation of Kv1.2 and K-Shaw2 by sevoflurane. Following functional expression of these Kv channels in Xenopus oocytes, we found that converse mutations in Kv1.2 (G329T) and K-Shaw2 (T330G) dramatically enhance and inhibit the potentiation of the corresponding conductances by sevoflurane, respectively. Additionally, Kv1.2-G329T impairs voltage-dependent gating, which suggests that Kv1.2 modulation by sevoflurane is tied to gating in a state-dependent manner. Toward creating a minimal Kv1.2 structural model displaying the putative sevoflurane binding sites, we also found that the positive modulations of Kv1.2 and Kv1.2-G329T by sevoflurane and other general anesthetics are T1-independent. In contrast, the positive sevoflurane modulation of K-Shaw2 is T1-dependent. In silico docking and molecular dynamics-based free-energy calculations suggest that sevoflurane occupies distinct sites near the S4-S5 linker, the pore domain and around the external selectivity filter. We conclude that the positive allosteric modulation of the Kv channels by sevoflurane involves separable processes and multiple sites within regions intimately involved in channel gating.
???displayArticle.pubmedLink???
26599217
???displayArticle.pmcLink???PMC4657974 ???displayArticle.link???PLoS One ???displayArticle.grants???[+]
Fig 2. Analysis of G-V relations from Kv1.2, ÎT1-Kv1.2, K-Shaw2, K-Shaw2 T330G and ÎT1-K-Shaw2.(A) Best-fit Boltzmann parameters (V1/2, z and Gmax) from individual paired measurements before (Ctr) and after exposure to 1 mM sevoflurane (Sevo). Each pair of symbols connected by a solid line represents an individual paired experiment (Materials and Methods). The Gmax graphs depict raw values before normalization (in mS). The P value resulting from a paired Student-t test is shown above each graph, and the red marks indicate the mean values of the sample. (B)â(E) are as described for panel A. The number oocytes examined for each Kv channel was 6, 6, 4, 6 and 6, respectively.
Fig 3. Modulation of the Kv1.2 channel by general anesthetics.(A) Effects of general anesthetics on the whole-oocyte Kv1.2 currents evoked by a voltage step to +60 mV from a holding voltage of -100 mV. Black, red and grey current traces correspond to control, anesthetic-exposed, and washout, respectively. The scale bars indicate 50 ms and 0.5 μA. (B) Concentration-response relations of various general anesthetics acting on the Kv1.2 channel. Solid lines are the best fits assuming the Hill equation for sevoflurane and n-butanol (Materials and Methods). Considering the magnitude of the change and the concentrations tested, only sevoflurane and n-butanol produced reliable Hill equation fits. N = 5â7 oocytes for each concentration. Best-fit parameters are summarized in Table 1.
Fig 4. Modulation of Kv1.2 FRAKT by general anesthetics.(A) Sequence alignment of the S4-S5 linker from K-Shaw2 (314â332) and Kv1.2 (313â331) channels. Starting and ending residue numbers of the shown segments are indicated. In Kv1.2, the blue colored residues were swapped for the red colored residues in K-Shaw2 to create the Kv1.2 FRAKT mutant channel. (B) Effects of general anesthetics on whole-oocyte Kv1.2-FRAKT currents evoked by a voltage step to +60 mV from a holding voltage of -100 mV. Black, red and grey current traces correspond to control, anesthetic-exposed, and washout, respectively. The scale bars indicate 50 ms and 0.5 μA. (C) Concentration-response relations of various general anesthetics acting on the Kv1.2 FRAKT channel. Solid lines are the best fits assuming the Hill equation (propofol and n-butanol) or a double Hill equation (sevoflurane, isoflurane, and halothane) (Materials and Methods). Due to the small magnitude of the chloroform results, no reliable Hill equation fit could be obtained. N = 5â8 oocytes for each concentration. Best-fit parameters are summarized in Table 1.
Fig 5. Kv1.2 G329T recapitulates the magnified positive modulation of Kv1.2 FRAKT by sevoflurane.(A) Effects of 1 mM sevoflurane on mutant whole-oocyte Kv1.2 currents evoked by a voltage step to +60 mV from a holding voltage of -100 mV. Black, red and grey current traces correspond to control, anesthetic-exposed, and washout, respectively. The scale bars indicate 50 ms and 1 μA. (B) Concentration-response relations of various general anesthetics acting on wild type and mutant Kv1.2 currents. Solid lines are the best fits assuming the double Hill equation (Materials and Methods). N = 4â8 oocytes for each dose. Best-fit parameters are summarized in Table 1.
Fig 6. Novel G-V relations of Kv1.2 FRAKT and Kv1.2 G329T in the absence and presence of sevoflurane.(A) Families of whole-oocyte Kv1.2 FRAKT currents in the absence (left) and presence of 1 mM sevoflurane (right). Currents were evoked by step depolarizations from a holding voltage of -100 mV. The steps were delivered in increments of 10 mV from -90 to 130 mV. The scale bars indicate 100 ms and 2 μA. (B) Families of whole-oocyte Kv1.2 G329T currents in the absence (left) and presence of 1 mM sevoflurane (right). Currents were evoked by step depolarizations from a holding voltage of -100 mV. The steps were delivered in increments of 10 mV from -90 to 70 mV. The scale bars indicate 100 ms and 1 μA. (C) G-V relations of Kv1.2 FRAKT (red) and Kv1.2 G329T (blue) under control (open) or with 1 mM Sevoflurane (filled) (N = 6, 4, respectively). Solid lines are the best fits assuming a double Boltzmann equation (Materials and Methods). The best-fit parameters are summarized in Table A in S1 File.
Fig 7. Analysis of bimodal G-V relations from Kv1.2 FRAKT, Kv1.2 G329T and ÎT1-Kv1.2 FRAKT.(A) Best-fit double Boltzmann parameters (V1/2,1, z1, Gmax,1, V1/2,2, z2, Gmax,2) and Vmed from individual paired measurements before (Ctr) and after exposure to 1 mM sevoflurane (Sevo). Each pair of symbols connected by a solid line represents an individual paired experiment (Materials and Methods). The Gmax graphs depict raw values before normalization (in mS). The P value resulting from a paired Student-t test is shown above each graph, and the red marks indicate the mean values of the sample. (B)â(C) are as described for panel A. The number oocytes examined for each Kv channel was 6, 4, 5, respectively.
Fig 8. The T330G mutation eliminates the voltage-dependent potentiation of the K-Shaw2 conductance by sevoflurane.(A) Families of whole-oocyte K-Shaw2 (N = 4) and K-Shaw2 T330G (N = 6) currents in the absence (left) and presence of 1 mM sevoflurane (right). Currents were evoked by step depolarizations from a holding voltage of -100 mV. The steps were delivered in increments of 10 mV from -90 to +100 mV. The scale bars indicate 100 ms and 1 μA. (B) G-V relations of K-Shaw2 (black) and K-Shaw2 T330G (red) in the absence (open) and presence of 1 mM sevoflurane (filled). Solid lines are the best-fits to the Boltzmann equation. Best-fit parameters are summarized in Fig 2 and Table A in S1 File. (C) The voltage dependence of the conductance ratio (GSevo/G0) K-Shaw2 (black) and K-Shaw2 T330G (red).
Fig 9. Positive modulation by sevoflurane is T1 domain-independent in Kv1.2 and Kv1.2-FRAKT, and T1 domain-dependent in K-Shaw2.(A) Concentration-response relations of various general anesthetics acting on ÎT1-Kv1.2. Solid line is the best fit to the Hill equation for n-butanol. (B) Concentration-response relations of various general anesthetics acting on ÎT1-Kv1.2 FRAKT. Solid lines are the best fits to the Hill equation (propofol and n-butanol) or double Hill equation (sevoflurane, isoflurane, and halothane). Best-fit parameters for results in panels A and B are summarized in Table 1. (C) Concentration-response relations of sevoflurane acting on K-Shaw2 and ÎT1-K-Shaw2. Solid line is the best-fit double Hill equation to the K-Shaw2 data with the following parameters: K1 = 0.08 mM, A1 = 0.18, nH1 = 1, K2 = 4 mM, A2 = 1.4, nH2 = 1. These parameters are similar to those previously published for wild type K-Shaw2 (Table 1) [7]. K-Shaw2 and ÎT1-K-Shaw2 were tested at +60 mV. N = 2â8 oocytes for each dose.
Fig 10. Putative sevoflurane binding sites in the Kv1.2 channel.(A) Representation of four distinct sevoflurane binding locations on Kv1.2: site 1 (light blue), 2 (blue), 3 (black) and 4 (purple). Each pair of subunits is represented in green and orange. Mutation G329T is highlighted yellow. (B) Close-up view of ligand binding sites and mutation. Note that site 2 is in close proximity to the mutated residue G329T. (C) Binding constants of individual sevoflurane sites. These estimates were obtained using the LIE method as described under S1 File. O and C stand for activation-open and resting-closed conformations of the channel.
Fig 1. Positive modulation of the Kv1.2 conductance by sevoflurane.(A) Families of whole-oocyte Kv1.2 currents before (left) and after exposure to 1 mM sevoflurane (center). Currents were evoked by step depolarizations from a holding voltage of -100 mV. The steps were delivered in increments of 10 mV from -50 to +50 mV. The overlay (right) directly compares selected currents in the absence (black) and presence (red) of sevoflurane (currents evoked by steps to the indicated voltages). (B) Normalized G-V relations of Kv1.2 in the absence (black) and presence of 1 mM sevoflurane (red) (N = 6). The solid lines are the best-fit Boltzmann functions. G
max is the control maximum conductance before exposure to sevoflurane (Materials and Methods). The mean best-fit parameters are summarized in Table A in S1 File. (C) The voltage dependence of the Kv1.2 conductance ratio (G
Sevo/G
0). This ratio was calculated from paired measurements of the G-V relations before (G
0) and after exposure to sevolfurane (G
Sevo).
Alkire,
Thalamic microinfusion of antibody to a voltage-gated potassium channel restores consciousness during anesthesia.
2009, Pubmed
Alkire,
Thalamic microinfusion of antibody to a voltage-gated potassium channel restores consciousness during anesthesia.
2009,
Pubmed
Aqvist,
A new method for predicting binding affinity in computer-aided drug design.
1994,
Pubmed
Barber,
Molecular mapping of general anesthetic sites in a voltage-gated ion channel.
2011,
Pubmed
Barber,
Modulation of a voltage-gated Na+ channel by sevoflurane involves multiple sites and distinct mechanisms.
2014,
Pubmed
Barber,
Novel activation of voltage-gated K(+) channels by sevoflurane.
2012,
Pubmed
,
Xenbase
Bhattacharji,
Inhalational anaesthetics and n-alcohols share a site of action in the neuronal Shaw2 Kv channel.
2010,
Pubmed
,
Xenbase
Bixby,
Zn2+-binding and molecular determinants of tetramerization in voltage-gated K+ channels.
1999,
Pubmed
Blunck,
Mechanism of electromechanical coupling in voltage-gated potassium channels.
2012,
Pubmed
Chowdhury,
Interfacial gating triad is crucial for electromechanical transduction in voltage-activated potassium channels.
2014,
Pubmed
,
Xenbase
Cushman,
Voltage dependent activation of potassium channels is coupled to T1 domain structure.
2000,
Pubmed
Delemotte,
Intermediate states of the Kv1.2 voltage sensor from atomistic molecular dynamics simulations.
2011,
Pubmed
Franks,
General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal.
2008,
Pubmed
Hemmings,
Sodium channels and the synaptic mechanisms of inhaled anaesthetics.
2009,
Pubmed
Herold,
Sodium channels as targets for volatile anesthetics.
2012,
Pubmed
Hoshi,
C-type inactivation of voltage-gated K+ channels: pore constriction or dilation?
2013,
Pubmed
Huang,
CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data.
2013,
Pubmed
Humphrey,
VMD: visual molecular dynamics.
1996,
Pubmed
Kopp Lugli,
Anaesthetic mechanisms: update on the challenge of unravelling the mystery of anaesthesia.
2009,
Pubmed
Lai,
The distribution and targeting of neuronal voltage-gated ion channels.
2006,
Pubmed
Ledwell,
Mutations in the S4 region isolate the final voltage-dependent cooperative step in potassium channel activation.
1999,
Pubmed
,
Xenbase
Li,
Single-channel basis for conductance increase induced by isoflurane in Shaker H4 IR K(+) channels.
2001,
Pubmed
,
Xenbase
Lioudyno,
Shaker-related potassium channels in the central medial nucleus of the thalamus are important molecular targets for arousal suppression by volatile general anesthetics.
2013,
Pubmed
Long,
Voltage sensor of Kv1.2: structural basis of electromechanical coupling.
2005,
Pubmed
Minor,
The polar T1 interface is linked to conformational changes that open the voltage-gated potassium channel.
2000,
Pubmed
,
Xenbase
Pathak,
The cooperative voltage sensor motion that gates a potassium channel.
2005,
Pubmed
,
Xenbase
Phillips,
Scalable molecular dynamics with NAMD.
2005,
Pubmed
Robbins,
Kv1.1 and Kv1.2: similar channels, different seizure models.
2012,
Pubmed
Robinson,
Coupled tertiary folding and oligomerization of the T1 domain of Kv channels.
2005,
Pubmed
,
Xenbase
Schoppa,
The size of gating charge in wild-type and mutant Shaker potassium channels.
1992,
Pubmed
Schoppa,
Activation of Shaker potassium channels. III. An activation gating model for wild-type and V2 mutant channels.
1998,
Pubmed
,
Xenbase
Smith-Maxwell,
Uncharged S4 residues and cooperativity in voltage-dependent potassium channel activation.
1998,
Pubmed
,
Xenbase
Smith-Maxwell,
Role of the S4 in cooperativity of voltage-dependent potassium channel activation.
1998,
Pubmed
,
Xenbase
Treptow,
Environment of the gating charges in the Kv1.2 Shaker potassium channel.
2006,
Pubmed
Trimmer,
Localization of voltage-gated ion channels in mammalian brain.
2004,
Pubmed
Trott,
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
2010,
Pubmed
Wang,
Zn2+-dependent redox switch in the intracellular T1-T1 interface of a Kv channel.
2007,
Pubmed
,
Xenbase
Wang,
Voltage-dependent gating rearrangements in the intracellular T1-T1 interface of a K+ channel.
2006,
Pubmed
,
Xenbase
Zagotta,
Shaker potassium channel gating. III: Evaluation of kinetic models for activation.
1994,
Pubmed
,
Xenbase